[
    [
        {
            "time": "2019-02-06",
            "original_text": "Edited Transcript of LLY earnings conference call or presentation 6-Feb-19 2:00pm GMT",
            "features": {
                "keywords": [
                    "LLY",
                    "earnings",
                    "conference",
                    "call",
                    "presentation"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Edited Transcript of LLY earnings conference call or presentation 6-Feb-19 2:00pm GMT",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 5,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-02-07",
            "original_text": "Sanofi (SNY) Q4 Earnings Top, Genzyme Unit Drives Sales Growth",
            "features": {
                "keywords": [
                    "Sanofi",
                    "SNY",
                    "Q4",
                    "Earnings",
                    "Genzyme",
                    "Sales",
                    "Growth"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Sanofi (SNY) Q4 Earnings Top, Genzyme Unit Drives Sales Growth",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-02-07",
            "original_text": "Stock Market News For Feb 7, 2019",
            "features": {
                "keywords": [
                    "Stock",
                    "Market",
                    "News"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Stock Market News For Feb 7, 2019",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 3,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 4,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-02-07",
            "original_text": "5 Reasons Eli Lilly Investors Look Can Look Past Lartruvo's Failure",
            "features": {
                "keywords": [
                    "Eli",
                    "Lilly",
                    "Investors",
                    "Look",
                    "Past",
                    "Lartruvo",
                    "Failure"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "5 Reasons Eli Lilly Investors Look Can Look Past Lartruvo's Failure",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]